Solid Organ Transplant Rejection

• CLINICAL_TRIALS trial_result · 2025-09-02
  Clinical Trial Update: Exercise Training and Kidney Transplantation [NA]

  A completed clinical trial evaluated exercise training in kidney transplant recipients and examined effects on solid organ transplant reject…

• CLINICAL_TRIALS research · 2024-07-29
  Clinical Trial Update: Expanded Access for Use of ExoFlo in Abdominal Solid Organ Transplant Patients

  This document reports an Expanded Access update for ExoFlo used in abdominal solid organ transplant patients. The program is listed as no lo…

• FDA approval · 2021-08-11
  FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Sandoz Inc)

  FDA approved a supplemental application for mycophenolate mofetil submitted by Sandoz Inc.

• FDA approval · 2021-08-11
  FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  The FDA approved a supplemental application for mycophenolate mofetil from Teva Pharmaceuticals USA, expanding its labeling.

• FDA approval · 2021-08-11
  FDA Approved: MYCOPHENOLIC ACID — Supplemental Application (Apotex Corp)

  FDA approved a supplemental application for mycophenolic acid submitted by Apotex Corp.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2021-01-15
  FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (VistaPharm, LLC)

  FDA granted a supplemental approval for Mycophenolate mofetil from VistaPharm, LLC under ANDA210370.

• CLINICAL_TRIALS safety_alert · 2014-02-10
  Clinical Trial Update: Assess the Risk of Solid Organ Transplant Rejection Following Vaccination With Pandemrix™ in UK

  An update on a UK study evaluating whether Pandemrix influenza vaccine is associated with an increased risk of solid organ transplant reject…

• FDA label_change · 2013-09-27
  FDA Approved: MYFORTIC — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approved a supplemental application for Myfortic (mycophenolic acid) from Novartis. The approval updates the labeling to reflect changes…